Ains-To examine whether a therapeutic dose of ultrasound waves, when directed through the thoracic wall to the spleen, would significantly affect the platelet count in patients with stable immune thrombocytopenic purpura (ITP).
Splenic macrophages are important effector cells in the sequestration and destruction of antibody coated platelets in immune thrombocytopenic purpura (ITP). This is shown most clearly by spleen removal, which induces an early and dramatic rise in the platelet count in most patients. Other treatments for ITP are unsatisfactory because they have substantial side effects, are expensive, or are slow to act.
Ultrasound waves have been used successfully for many years to treat localised, painful, and inflammatory disorders, and have an extremely good safety record.' Some of the biological effect of ultrasound is mediated directly by its thermal effect on tissues. At thermal and subthermal intensities, ultrasound waves induce the formation of microbubbles within blood and other tissues and it is thought that this "cavitation effect" damages the integrity and function of cell membranes and intracellular organelles. '4 Interference with macrophage function in particular is believed to be of importance in mediating the beneficial effect of ultrasound in inflammatory conditions.
Previous investigators have shown that ultrasound has significant bioeffects on the immune system7 and the mononuclear phagocytic system.8-'0 Saad and Williams" showed that therapeutic ultrasound at a similar intensity to that used in this study, applied over the umbilical region of rats, caused a short lived (< 30 minutes) reduced clearance of 99mTc-labelled colloid from the blood. The magnitude of this effect was directly proportional to the product of the intensity and duration of ultrasound treatment.
Methods
Patients with thrombocytopenia included thirteen with ITP and one patient with hypersplenism secondary to non-Hodgkin's lymphoma (NHL) (Case 7) (table 1). All patients had had previous bone marrow aspirate examinations that showed normal or increased numbers of megakaryocytes. Recently diagnosed patients, pregnant patients, or those with unstable platelet counts (such as those recently started on drug treatment) were excluded. Healthy controls comprised healthy, volunteer members of the laboratory staff.
Patients were asked to rotate about 60°on to their right-hand side from a supine position and to place their left hand behind their head. The spleen was then localised with conventional diagnostic ultrasound and the longitudinal and transverse diameters of the spleen were measured; the product gave an estimate of splenic surface area. The overlying skin was marked with a skin pencil to show the ultrasonographic window of access to the organ. The subjects remained in the position described, for ultrasound treatment.
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these unusual kinetics. The platelet count ase 6 had ITP that failed to respond to returned to baseline within nine hours in all ids and vincristine and in whom there cases, which suggests an effect on metabolino discernible platelet increase after ultra-cally active cells (such as splenic macrophages id treatment. There was a moderate in ITP) rather than some other longer term onse to intravenous immunoglobulin with process such as the rate of platelet antibody se in her platelet count from 20 to production or cell replication. ultrasound. These data suggest that response to splenic ultrasound may predict the response to splenectomy in ITP and further studies are in process to examine this point. It may be possible to achieve a higher platelet increment by varying the dose intensity or duration of treatment. It would be of interest to know whether the platelet increment would increase or decrease with repeated ultrasound treatments. Case 16 was the only patient who received repeated treatments (three treatments on alternate days), and she showed no significant variation in response. There is no evidence from this study that the dose of ultrasound was harmful. Ultrasound has been applied by others in similar doses to the chest and abdomen without a single report of serious adverse effect. [22] [23] [24] [25] [26] The doses of ultrasound in our study were determined by the safety limits used by physiotherapists. Little is known of the toxicity of ultrasound at higher doses and careful evaluation of toxicity is required before more intensive dose schedules could be justified. Higher doses may ultimately be found to be safe and may result in clinically meaningful platelet increments.
We tested a single ultrasound frequency (1 MHz) in this study, and other frequencies could result in higher platelet increments. The depth of the spleen below the skin is such, however, that ultrasound frequencies greater than 1X5 MHz will not reach it effectively; and waves with frequencies less than 05 MHz will penetrate the organ without being absorbed effectively. Also, the spleen varies in position from subject to subject and it moves with respiration. Furthermore, as soft tissue-air interfaces are virtually impermeable to ultrasound, the presence of the lower lobe of the left lung precludes access to the upper part of the organ. Despite these geometrical constraints, we are confident that the greater bulk of the tissue of the spleen was exposed to ultrasound although the exact dose delivered was impossible to determine.
To our knowledge, this is the first study which shows that ultrasound can be used to modulate the platelet count, albeit transiently, in patients with ITP. Further evaluation of the toxicity of ultrasound is advised before higher dose schedules are contemplated.
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